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The binding of 3H-Iabelled drug molecules to membranes of living cehs gives rise to photon emission from 
tryptophan residues at proteinaceous binding sites. This phenomenon, called condensed phase 
radioluminescence, has been used to measure non-invasively the kinetics of [3H]nitrendipine binding and 
dissociation on the same samples of cultured beating cardiac myocytes. Signal arose only from bound drug 
molecules. Binding was monoexponential (7 = 5.5 min) as was dissociation (14.3 min). Prein~ubating cells 
with non-radioactive nifedipine reduced the amplitude and rate of [3H]nitrendipine but not of 
13H]dihydroalprenoIoI binding. The potential uses of this phenomenon are discussed. 
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1. INTRODUCTION 
Radioligand binding studies have revealed a 
great deal about drug-receptor and 
hormone-receptor interactions in many biological 
systems [I]. The method is essentially a steady- 
state method which is usually applied to membrane 
fractions prepared from tissues. The kinetics of 
binding can only be measured by repeated sampl- 
ing of a single incubation or by incubating in 
parallel a pooled tissue preparation and then con- 
structing a time course. One can never exclude the 
possibility that receptor modification or inactiva- 
tion has occurred during the isolation of the mem- 
brane fraction. In most such experiments, 
radioligand is presented to both sides of the 
bioiogicaf membrane, unlike in vivo. Vesicle 
preparations may be used for some tissues but 
these present additional problems of incomplete 
sealing and separating ‘right-side-out’ and ‘inside- 
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out’ vesicIes. These factors contribute to the pro- 
blems of differences in potency between organ 
bath and isolated membrane preparations not in- 
frequently observed. 
Ideally, one wants to measure on intact, living 
cells hormone or drug binding and its immediate 
membrane effects (the transduction phase) leading 
to the ultimate biological response. This is par- 
ticularly true when the biological response is dif- 
ficult to measure; e.g., in brain tissue. An advance 
in the techniques available is required to address 
these problems experimentahy. 
The P-decay from a tritiated molecule may be 
used to excite a fluorophore in a model membrane 
system [2]. When the tritium and the fluorophore 
are in close proximity, a signal results which may 
be detected using single photon counting techni- 
ques. The technique, tailed condensed phase 
radioluminescence (CPR), has been used to study 
changes in the surface area of phospholipid 
vesicles and to examine the effects of fatty acids on 
membrane charge [2,3 1. 
Here, we demonstrate that the binding of 3H- 
labefled molecules to the membranes of living celis 
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can give rise to photon emission from protein 
native to the membrane. We show that this CPR 
signal may be used to determine values for the 
half-time of [3H]nitrendipine association and 
dissociation with a single class of binding sites on 
beating myocytes of 5 + 1 min and 14.5 f 1 min 
respectively. This may form the basis of a powerful 
tool for studying non-invasively receptors in intact 
tissue. 
2. EXPERIMENTAL 
Suspensions of beating heart cells were prepared 
as in [4]. The mixed fibroblast and myocyte 
preparation was incubated in 14 cm culture plates 
for 30 min at 37°C to allow most of the fibroblasts 
to attach. The plates were then swirled gently and 
the myocyte-enriched supernatant seeded into 
1 cm3 wells of a tissue culture plate (Limbo) con- 
taining a washed and heat-sterilised 1 cm* glass 
coverslip (Chance-Propper Ltd). The plates were 
incubated for 4 days at 37°C and the medium 
changed on days 2 and 4. The medium used was a 
complete medium containing 10% newborn calf 
serum and 6.2 mM D-glucose as in [4]. On day 4, 
each of the coverslip cultures (by now monolayers) 
was transferred to a clean, sterile glass scintillation 
vial (Packard) under stringent sterile conditions 
and 2 cm3 of oxygenated medium added before 
capping the vials. After 1 h incubation at 37”C, 
the vials were packed in an insulated polystyrene 
container and transported by airline cabin freight 
to Switzerland. The cells arrived in good condition 
and, after an initial 1 day incubation and medium 
change, the cells beat as a synchronous monolayer 
at rates in excess of 60 min-’ at 20°C. CPR 
measurements were made after the second day in 
Switzerland (culture day 6). 
CPR was detected using an SLM fluorimeter 
equipped for single photon counting. The 
photomultiplier was arranged to be 4 cm above a 
well into which the coverslip cuRures and 450 mm3 
of medium was placed. The entire assembly was 
mounted in a light-tight box. All experiments were 
carried out at room temperature (about 20°C). 
Photons were counted for 30 s periods, averaged 
and recorded as counts per second (cps). 
Cells were added to 450 mm3 of medium con- 
taining 2.1 pM [3H]nitrendipine (New England 
Nuclear), an antagonist of the slow calcium chan- 
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nel [5], and the CPR signal observed until 
equilibrium was reached. The medium was then 
aspirated off the cells and replaced with non- 
radioactive medium. The subsequent decay in the 
CPR signal was used to obtain the kinetics of 
dissociation of the bound drug. Experiments were 
also performed using 2.1 PM [3H]dihydroalpreno- 
101 (Amersham International), a P-receptor anta- 
gonist [6], and on cells preincubated for 20 min at 
37°C with medium containing 0.1 PM nifedipine, 
another slow channel antagonist. 
3. RESULTS 
Fig.lA shows that adding coverslip cultures of 
cells to medium containing [3H]nitrendipine in- 
creases the CPR signal observed. The signal may 
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Fig. 1. The association and dissociation of 
[‘Hlnitrendipine with isolated myocytes. The time 
courses of CPR signal resulting from the association (A) 
and dissociation (B) of [3H]nitrendipine with isolated 
cardiac myocytes in culture is shown. Myocytes were 
added at time 0. The initial signal observed before the 
addition of the cells is caused by the dark current of the 
phototube and the stopping radiation of the tritium. 
Semi-logarithmic transformations of the data for (C) 
association and (D) dissociation. (---) Baselines for 
the transformation in (A,B); (-) 7 of 5.5 min (C) 
and 14.5 min (D). 
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be blocked by glass indicating that it is in the 
ultraviolet frequency range and therefore, in this 
system, arises from tryptophan. Adding cells in the 
absence of any tritium did not alter the 
background count rate. The signal must therefore 
arise from [3H]nitrendipine binding to pro- 
teinaceous ites on the myocyte membranes. Very 
little signal comes from [3H]nitrendipine in solu- 
tion. There is also no interference from any intrin- 
sic chemiluminescence of the cells under these 
conditions. 
The kinetics of [3H]nitrendipine binding are 
monoexponential (panel C). From this it may be 
inferred that CPR is monitoring the drug binding 
to a single class of proteinaceous binding sites. 
Theoretically, the tritium and the fluorophore 
must be within about 50 nm in the membrane for 
a CPR signal to be observed [2,3]. So if the 
[‘Hlnitrendipine is also binding to non-protein 
binding sites in these experiments, then the con- 
tribution to the CPR signal of drug binding to 
these sites is negligible. Furthermore, if there were 
a superimposed conformational change at one pro- 
tein binding site or if there were more than one ma- 
jor binding protein (having different kinetic con- 
stants), then the kinetics observed by CPR would 
be more complex. 
Monoexponential kinetics of dissociation were 
also observed (fig.lD) when the medium on the 
same cells was replaced by medium containing no 
radioactivity. The half-time of dissociation was 
14.5 f 1 min. The cells continued to beat after a 
further change into maintenance medium at the 
end of the experiment. 
Cells were pre-incubated at 37°C for 20 min 
with 0.1 PM nifedipine before being added to 
medium containing 2.1 PM [3H]nitrendipine but 
no nifedipine. Under these circumstances a 33% 
lower amplitude and 70% slower rate of binding 
were observed. Pre-incubation with 1 PM 
nifedipine caused a marked reduction in the rate of 
[3H]nitrendipine binding. The amount of 
nifedipine bound to the myocytes which was car- 
ried over into the sample chamber is not known, 
but its effect was to alter the kinetics of the CPR 
signal change produced by [3H]nitrendipine bind- 
ing. This is consistent with a competition for the 
single class of proteinaceous binding sites observed 
by CPR. 
[3H]Dihydroalprenolol was used to compare the 
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Fig.2. The association and dissociation of 
[‘H]dihydroalprenoloI with isolated myocytes. The time 
course of the CPR signal resulting from the association 
(A) and dissociation (B) of [3H]dihydroalprenolol are 
shown. The medium was replaced at time 0. Semi- 
logarithmic transformations of the data for association 
and dissociation are shown (C,D), assuming the 
baselines indicated at (---) in (A,B); (-) 7 of 
6.8 min (C) and 7 = 14.8 min (D). 
effects of the calcium slow channel antagonists 
above with an antagonist of the &receptor. The 
binding and dissociation kinetics for [3H]dihydro- 
alprenolol were both monoexponential with half 
times of 6 f 1 min and 14.8 f 1 min, respectively 
(fig.2). Pre-incubation of the cells with nifedipine 
had no effect on these parameters. This indicates 
that CPR is applicable to systems in addition to the 
calcium slow channel. It also shows that nifedipine 
does not exert its effect in the nitrendipine system 
other than at the binding site. 
4. DISCUSSION 
The results demonstrate that CPR can be used to 
measure the kinetics associated with binding of 
drug molecules to intact, living cells. The CPR 
signal observed when [3H]nitrendipine binds ap- 
pears to arise from a single class of proteinaceous 
binding sites at which nifedipine and nitrendipine 
187 
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compete. This is likely to be the dihydropyridine 
binding site of the calcium slow channel [5], but a 
contribution of displaceable binding (with similar 
kinetics) to other proteins cannot be ruled out. A 
formal pharmacological evaluation of the binding 
site is in train. The sensitivity of the measurement 
is sufficiently high to permit the determination of 
the kinetics of association and dissociation on a 
single sample. 
The rate of dissociation of [3H]nitrendipine is 
similar to values previously obtained by classical 
techniques [5]. The advantage of CPR is that the 
measurements were made non-invasively on intact, 
viable cells. This overcomes the major problem of 
classical binding studies, where inactivation or 
modification of receptors may occur during the 
isolation of membrane fractions. Furthermore, 
CPR obviates the measurement of binding to non- 
viable cells as dead cells would have already 
detached from the monolayer and not been includ- 
ed in the sample chamber. CPR only measures 
bound 3H-labelled drug molecules and so no 
separation of bound and free ligand is required. 
This means that there is no error introduced into 
the measurements by the use of rapid separation 
techniques. This advantage may ultimately permit 
analysis using CPR of binding kinetics of the order 
of 10 s. 
These experiments demonstrate that CPR has a 
sensitivity comparable to other luminescence 
techniques and has adequate sensitivity to be 
useful in addressing biologically relevant problems 
in native membranes. An improvement of a factor 
of 10 in drug concentration may be possible using 
modified apparatus. The multiplicity of protein 
molecules in natural membranes gives many poten- 
tial fluorophores, but the energy transfer processes 
involved and the specificity of drug binding are 
such that almost all of the signal probably arises 
from specific binding sites. Even so, several dif- 
ferent tryptophan residues within the binding pro- 
tein probably emit photons. They do so against a 
background caused only by the ‘Stopping radiation 
in the medium [2,3]. This forms the limitation of 
sensitivity of the technique and may only be reduc- 
ed by decreasing the volume of the supernatant. 
The sensitivity of the measurement then depends 
solely on the statistics of counting. 
As in all fluorescence measurements, an external 
calibration is required to relate the signal intensity 
to the actual amount of material bound and thus 
obtain a KD for binding. Given this limitation, 
more information can be obtained by CPR and 
more quickly than by classical binding studies. For 
example, the aggregation of drug-receptor com- 
plexes could be measured in intact cells [2,3]. As 
tritiated agonists, partial agonists and antagonists 
for the same receptor may be used, and the interac- 
tion of several partial agonists or antagonists with 
one 3H-labelled agonist may be measured, CPR 
may eventually be used to map receptors and il- 
lustrate structure-activity relationships on living 
cells. 
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